Home / 092730.KQ : KOE

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does 092730.KQ make money? Does 092730.KQ have pricing power? What's the Earnings Whisper? Will 092730.KQ profit more as the business scales? What is 092730.KQ's management track record? Is 092730.KQ's current price justified?

NeoPharm Co. Ltd.

₩22250.00 +$3260.00 (+17.17%)

KOE · 30 Oct 2026 06:30 UTC

Previous Close

₩22300.00

Day Range

₩21600.00₩22800.00

Year Range

₩15590.00₩26000.00

Market Cap

348.02B

AVG Volume

63.38K

Trailing/Forward PE

11.36/8.57

PEG ratio

0.51

Dividend Yield

2.70%

Next Earnings Date

2026-11-06

Primary Exchange

KOSDAQ

Revenue (KRW) · A

092730.KQ Revenue (KRW) by year
Period	Revenue (KRW)
2025	132.18B
2024	119.01B
2023	97.1B
2022	85.03B
2021	87.93B
2020	81.63B
2019	83.24B
2018	66.27B
2017	53.63B
2016	42.37B

Net Income (KRW) · A

092730.KQ Net Income (KRW) by year
Period	Net Income (KRW)
2025	27.82B
2024	23.06B
2023	23.21B
2022	17.03B
2021	17.71B
2020	18.13B
2019	19.25B
2018	15.37B
2017	11.56B
2016	7.74B

Operating Income (KRW) · A

092730.KQ Operating Income (KRW) by year
Period	Operating Income (KRW)
2025	28.77B
2024	24.65B
2023	25.31B
2022	21.44B
2021	22.43B
2020	21.9B
2019	22.96B
2018	19.16B
2017	14.06B
2016	9.65B

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (KRW) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 6 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

NeoPharm Co. Ltd.

Earnings: 092730.KQ

Video analysis: 092730.KQ

News: 092730.KQ

Similar companies